gabexate has been researched along with Stomach Neoplasms in 4 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sequential therapy consisting of methotrexate (MTX) and 5-FU was performed together with the administration of heparin and FOY in 10 cases of gastric cancer with disseminated intravascular coagulation (DIC) causing systemic bone metastasis." | 3.68 | [Sequential MTX and 5-FU therapy of gastric cancer with systemic bone metastasis and disseminated intravascular coagulation]. ( Ibuka, T; Imai, K; Ishiwata, J; Kobayashi, T; Monma, K; Ohno, T; Onozawa, Y; Sakaki, N; Sasaki, T; Tabata, I, 1992) |
| "Bone metastases from gastric cancer (GC) are considered a relatively uncommon finding; however, they are related to poorer prognosis." | 2.52 | Targeting mast cells in gastric cancer with special reference to bone metastases. ( Ammendola, M; De Sarro, G; Gadaleta, CD; Leporini, C; Marech, I; Oakley, C; Ranieri, G; Russo, E; Sacco, R; Sammarco, G, 2015) |
| "Thirty-four paired normal and gastric cancer tissues were tested to measure the IC50 of the gabexate mesylate." | 1.31 | Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment. ( Chung, HC; Jeung, HC; Kim, BS; Kim, JJ; Min, JS; Noh, SH; Rha, SY; Roh, JK, 2002) |
| "A case of advanced gastric cancer associated with metastatic carcinomatosis of the bone marrow, microangiopathic hemolytic anemia (MAHA) and disseminated intravascular coagulation (DIC) was reported." | 1.27 | [Microangiopathic hemolytic anemia associated with gastric cancer]. ( Hattori, T; Kanou, T; Kuramoto, J; Miura, K; Niimoto, M; Nosou, Y; Yanagawa, E; Yoshinaka, K, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leporini, C | 1 |
| Ammendola, M | 1 |
| Marech, I | 1 |
| Sammarco, G | 1 |
| Sacco, R | 1 |
| Gadaleta, CD | 1 |
| Oakley, C | 1 |
| Russo, E | 1 |
| De Sarro, G | 1 |
| Ranieri, G | 1 |
| Rha, SY | 1 |
| Jeung, HC | 1 |
| Roh, JK | 1 |
| Kim, JJ | 1 |
| Noh, SH | 1 |
| Min, JS | 1 |
| Kim, BS | 1 |
| Chung, HC | 1 |
| Kobayashi, T | 1 |
| Sasaki, T | 1 |
| Ibuka, T | 1 |
| Imai, K | 1 |
| Monma, K | 1 |
| Sakaki, N | 1 |
| Tabata, I | 1 |
| Ishiwata, J | 1 |
| Onozawa, Y | 1 |
| Ohno, T | 1 |
| Kanou, T | 1 |
| Nosou, Y | 1 |
| Yoshinaka, K | 1 |
| Yanagawa, E | 1 |
| Niimoto, M | 1 |
| Hattori, T | 1 |
| Miura, K | 1 |
| Kuramoto, J | 1 |
1 review available for gabexate and Stomach Neoplasms
| Article | Year |
|---|---|
Targeting mast cells in gastric cancer with special reference to bone metastases.
Topics: Animals; Antigens, CD34; Benzamides; Benzamidines; Bone and Bones; Bone Neoplasms; Bone Resorption; | 2015 |
3 other studies available for gabexate and Stomach Neoplasms
| Article | Year |
|---|---|
Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Cell Differentiation; Enzyme Inhibitors | 2002 |
[Sequential MTX and 5-FU therapy of gastric cancer with systemic bone metastasis and disseminated intravascular coagulation].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocol | 1992 |
[Microangiopathic hemolytic anemia associated with gastric cancer].
Topics: Adenocarcinoma; Aged; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Benzodiazep | 1986 |